Phase 0/1 Study of 212Pb-NG001 in mCRPC

Clinical trial NCT05725070 · COMPLETED

Trial details

NCT number: NCT05725070
Sponsor: ARTBIO Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2023-03-06
Primary completion: 2023-07-06
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.